Literature DB >> 31199466

Re: Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Laurel A Habel1, Diana S M Buist2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31199466      PMCID： PMC7019086          DOI： 10.1093/jnci/djz118

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Authors:  Marc D Ryser; Donald L Weaver; Fengmin Zhao; Mathias Worni; Lars J Grimm; Roman Gulati; Ruth Etzioni; Terry Hyslop; Sandra J Lee; E Shelley Hwang
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

2.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

3.  Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.

Authors:  Anthony J Maxwell; Karen Clements; Bridget Hilton; David J Dodwell; Andrew Evans; Olive Kearins; Sarah E Pinder; Jeremy Thomas; Matthew G Wallis; Alastair M Thompson
Journal:  Eur J Surg Oncol       Date:  2018-01-11       Impact factor: 4.424

4.  Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.

Authors:  Laurel A Habel; Ninah S Achacoso; Reina Haque; Larissa Nekhlyudov; Suzanne W Fletcher; Stuart J Schnitt; Laura C Collins; Ann M Geiger; Balaram Puligandla; Luana Acton; Charles P Quesenberry
Journal:  Breast Cancer Res       Date:  2009-11-18       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.